TickerFacts.

Company research / CAH

Cardinal Health Inc (CAH)

Build a valuation ↗↓ Download CSV

SEC name CARDINAL HEALTH INC · CIK 0000721371 · NYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries

  • Sector Wholesale Trade
  • Incorporated OH
  • Fiscal year ends Jun 30

For the year ended 2026-06-30, Cardinal Health Inc reported revenue of $254.25B. Revenue grew 14.2% from the prior annual period.

Key ratios (year ended 2026-06-30)

3.8%
Gross margin
1.0%
Operating margin
0.7%
Net margin
14.2%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-01

Headquarters locality: Dublin · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

Period ended2026-06-302025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
Revenue$254.25B$222.58B$226.83B$204.98B$181.33B$162.47B$152.92B$145.53B$136.81B$129.98B
Cost of Revenue$244.47B$214.41B$219.41B$198.10B$174.84B$155.69B$146.05B$138.70B$129.63B$123.43B
Gross Profit$9.77B$8.17B$7.41B$6.87B$6.48B$6.78B$6.87B$6.83B$7.18B$6.54B
Operating Income$2.61B$2.27B$1.24B$752.00M-$607.00M$472.00M-$4.10B$2.06B$126.00M$2.12B
Depreciation & Amortization$956.00M$790.00M$710.00M$692.00M$692.00M$783.00M$913.00M$1.00B$1.03B$717.00M
EBITDA$3.57B$3.06B$1.95B$1.44B$85.00M$1.25B-$3.19B$3.06B$1.16B$2.84B
Net Income$1.71B$1.56B$852.00M$330.00M-$938.00M$611.00M-$3.70B$1.36B$256.00M$1.29B
EPS (Diluted)$7.23$6.45$3.45$1.26-$3.37$2.08-$12.61$4.53$0.81$4.03
Total Assets$57.30B$53.12B$45.12B$43.35B$43.88B$44.45B$40.77B$40.96B$39.95B$40.11B
Shareholders' Equity-$2.88B-$2.78B-$3.21B-$2.96B-$709.00M$1.79B$1.79B$6.33B$6.06B$6.81B
Cash & Equivalents$4.86B$3.87B$5.13B$4.08B$4.72B$3.41B$2.77B$2.53B$1.76B$6.88B
Operating Cash Flow$5.17B$2.40B$3.76B$2.84B$3.17B$2.43B$1.96B$2.72B$2.77B$1.18B
Capital Expenditures$649.00M$547.00M$511.00M$481.00M$387.00M$400.00M$375.00M$328.00M$384.00M$387.00M
Free Cash Flow$4.53B$1.85B$3.25B$2.36B$2.79B$2.03B$1.58B$2.39B$2.38B$797.00M
Share Repurchases$1.36B$765.00M$750.00M$2.00B$1.00B$200.00M$350.00M$600.00M$550.00M$600.00M
Dividends Paid$491.00M$494.00M$499.00M$525.00M$559.00M$573.00M$569.00M$577.00M$581.00M$577.00M
Dividends Per Share$2.04$2.02$2.00$1.98$1.96$1.94$1.92$1.91$1.85$1.80
Weighted Average Diluted Shares237.00M242.00M247.00M262.00M279.00M294.00M293.00M301.00M315.00M320.00M
EPS (Basic)$7.27$6.48$3.48$1.27-$3.37$2.09-$12.61$4.55$0.82$4.06

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView